Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
46
QSI Quote, Financials, Valuation and Earnings
Last price:
$1.45
Seasonality move
:
3.64%
Day range:
$1.41 - $1.49
52-week range:
$0.95 - $5.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
81.73x
P/B ratio:
1.32x
Volume:
3.7M
Avg. volume:
6.3M
1-year change:
20%
Market cap:
$310.3M
Revenue:
$3.1M
EPS (TTM):
-$0.66
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
QSI
Quantum-Si, Inc.
|
$599.3K | -$0.12 | -36.07% | -42.58% | $2.85 |
|
CATX
Perspective Therapeutics, Inc.
|
$206.8K | -$0.32 | -9.65% | -37.91% | $12.3077 |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$806.3K | -$0.04 | 272.5% | -33.67% | $2.60 |
|
VTAK
Catheter Precision, Inc.
|
$310K | -$0.20 | 118.75% | -11.57% | -- |
|
XTNT
Xtant Medical Holdings, Inc.
|
$28.5M | -- | 2.34% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
QSI
Quantum-Si, Inc.
|
$1.44 | $2.85 | $310.3M | -- | $0.00 | 0% | 81.73x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.4000 | $12.3077 | $178.4M | -- | $0.00 | 0% | 162.73x |
|
PMI
Picard Medical
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
VNRX
VolitionRX Ltd.
|
$0.30 | $2.60 | $36.8M | -- | $0.00 | 0% | 20.54x |
|
VTAK
Catheter Precision, Inc.
|
$2.38 | -- | $2.9M | 0.40x | $0.00 | 0% | 11.19x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.62 | $1.50 | $86.2M | 60.39x | $0.00 | 0% | 0.67x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
QSI
Quantum-Si, Inc.
|
1.92% | 1.064 | 1.52% | 10.24x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.691 | 1.3% | 8.47x |
|
PMI
Picard Medical
|
-- | 0.000 | -- | -- |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.566 | 15.4% | 0.04x |
|
VTAK
Catheter Precision, Inc.
|
68.63% | -0.348 | 537.37% | 0.41x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 2.955 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
QSI
Quantum-Si, Inc.
|
-$979K | -$24.4M | -49.36% | -51.75% | -4419.57% | -$32.9M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
VTAK
Catheter Precision, Inc.
|
-$320K | -$3M | -79.27% | -192.05% | -1336.73% | -$2.2M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
Quantum-Si, Inc. vs. Competitors
-
Which has Higher Returns QSI or CATX?
Perspective Therapeutics, Inc. has a net margin of -6467.94% compared to Quantum-Si, Inc.'s net margin of -12425.36%. Quantum-Si, Inc.'s return on equity of -51.75% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital QSIQuantum-Si, Inc.-177.36% -$0.17 $239.8M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About QSI or CATX?
Quantum-Si, Inc. has a consensus price target of $2.85, signalling upside risk potential of 97.92%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 412.82%. Given that Perspective Therapeutics, Inc. has higher upside potential than Quantum-Si, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Quantum-Si, Inc..
Company Buy Ratings Hold Ratings Sell Ratings QSIQuantum-Si, Inc.2 1 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is QSI or CATX More Risky?
Quantum-Si, Inc. has a beta of 2.983, which suggesting that the stock is 198.267% more volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.
-
Which is a Better Dividend Stock QSI or CATX?
Quantum-Si, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quantum-Si, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QSI or CATX?
Quantum-Si, Inc. quarterly revenues are $552K, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Quantum-Si, Inc.'s net income of -$35.7M is lower than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Quantum-Si, Inc.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quantum-Si, Inc. is 81.73x versus 162.73x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QSIQuantum-Si, Inc.81.73x -- $552K -$35.7M CATXPerspective Therapeutics, Inc.162.73x -- $209K -$26M
-
Which has Higher Returns QSI or PMI?
Picard Medical has a net margin of -6467.94% compared to Quantum-Si, Inc.'s net margin of --. Quantum-Si, Inc.'s return on equity of -51.75% beat Picard Medical's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital QSIQuantum-Si, Inc.-177.36% -$0.17 $239.8M PMIPicard Medical-- -- -- -
What do Analysts Say About QSI or PMI?
Quantum-Si, Inc. has a consensus price target of $2.85, signalling upside risk potential of 97.92%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that Quantum-Si, Inc. has higher upside potential than Picard Medical, analysts believe Quantum-Si, Inc. is more attractive than Picard Medical.
Company Buy Ratings Hold Ratings Sell Ratings QSIQuantum-Si, Inc.2 1 0 PMIPicard Medical0 0 0 -
Is QSI or PMI More Risky?
Quantum-Si, Inc. has a beta of 2.983, which suggesting that the stock is 198.267% more volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock QSI or PMI?
Quantum-Si, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quantum-Si, Inc. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QSI or PMI?
Quantum-Si, Inc. quarterly revenues are $552K, which are larger than Picard Medical quarterly revenues of --. Quantum-Si, Inc.'s net income of -$35.7M is higher than Picard Medical's net income of --. Notably, Quantum-Si, Inc.'s price-to-earnings ratio is -- while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quantum-Si, Inc. is 81.73x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QSIQuantum-Si, Inc.81.73x -- $552K -$35.7M PMIPicard Medical-- -- -- --
-
Which has Higher Returns QSI or VNRX?
VolitionRX Ltd. has a net margin of -6467.94% compared to Quantum-Si, Inc.'s net margin of -862.39%. Quantum-Si, Inc.'s return on equity of -51.75% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital QSIQuantum-Si, Inc.-177.36% -$0.17 $239.8M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About QSI or VNRX?
Quantum-Si, Inc. has a consensus price target of $2.85, signalling upside risk potential of 97.92%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.60 which suggests that it could grow by 767.53%. Given that VolitionRX Ltd. has higher upside potential than Quantum-Si, Inc., analysts believe VolitionRX Ltd. is more attractive than Quantum-Si, Inc..
Company Buy Ratings Hold Ratings Sell Ratings QSIQuantum-Si, Inc.2 1 0 VNRXVolitionRX Ltd.4 2 0 -
Is QSI or VNRX More Risky?
Quantum-Si, Inc. has a beta of 2.983, which suggesting that the stock is 198.267% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.
-
Which is a Better Dividend Stock QSI or VNRX?
Quantum-Si, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quantum-Si, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QSI or VNRX?
Quantum-Si, Inc. quarterly revenues are $552K, which are smaller than VolitionRX Ltd. quarterly revenues of $627.3K. Quantum-Si, Inc.'s net income of -$35.7M is lower than VolitionRX Ltd.'s net income of -$5.4M. Notably, Quantum-Si, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quantum-Si, Inc. is 81.73x versus 20.54x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QSIQuantum-Si, Inc.81.73x -- $552K -$35.7M VNRXVolitionRX Ltd.20.54x -- $627.3K -$5.4M
-
Which has Higher Returns QSI or VTAK?
Catheter Precision, Inc. has a net margin of -6467.94% compared to Quantum-Si, Inc.'s net margin of -1037.17%. Quantum-Si, Inc.'s return on equity of -51.75% beat Catheter Precision, Inc.'s return on equity of -192.05%.
Company Gross Margin Earnings Per Share Invested Capital QSIQuantum-Si, Inc.-177.36% -$0.17 $239.8M VTAKCatheter Precision, Inc.-141.59% -$1.70 $21.3M -
What do Analysts Say About QSI or VTAK?
Quantum-Si, Inc. has a consensus price target of $2.85, signalling upside risk potential of 97.92%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1496.69%. Given that Catheter Precision, Inc. has higher upside potential than Quantum-Si, Inc., analysts believe Catheter Precision, Inc. is more attractive than Quantum-Si, Inc..
Company Buy Ratings Hold Ratings Sell Ratings QSIQuantum-Si, Inc.2 1 0 VTAKCatheter Precision, Inc.0 0 0 -
Is QSI or VTAK More Risky?
Quantum-Si, Inc. has a beta of 2.983, which suggesting that the stock is 198.267% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.
-
Which is a Better Dividend Stock QSI or VTAK?
Quantum-Si, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quantum-Si, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QSI or VTAK?
Quantum-Si, Inc. quarterly revenues are $552K, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Quantum-Si, Inc.'s net income of -$35.7M is lower than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Quantum-Si, Inc.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quantum-Si, Inc. is 81.73x versus 11.19x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QSIQuantum-Si, Inc.81.73x -- $552K -$35.7M VTAKCatheter Precision, Inc.11.19x 0.40x $226K -$2.3M
-
Which has Higher Returns QSI or XTNT?
Xtant Medical Holdings, Inc. has a net margin of -6467.94% compared to Quantum-Si, Inc.'s net margin of 3.93%. Quantum-Si, Inc.'s return on equity of -51.75% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital QSIQuantum-Si, Inc.-177.36% -$0.17 $239.8M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About QSI or XTNT?
Quantum-Si, Inc. has a consensus price target of $2.85, signalling upside risk potential of 97.92%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 143.51%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Quantum-Si, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Quantum-Si, Inc..
Company Buy Ratings Hold Ratings Sell Ratings QSIQuantum-Si, Inc.2 1 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is QSI or XTNT More Risky?
Quantum-Si, Inc. has a beta of 2.983, which suggesting that the stock is 198.267% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.
-
Which is a Better Dividend Stock QSI or XTNT?
Quantum-Si, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quantum-Si, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QSI or XTNT?
Quantum-Si, Inc. quarterly revenues are $552K, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Quantum-Si, Inc.'s net income of -$35.7M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Quantum-Si, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 60.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quantum-Si, Inc. is 81.73x versus 0.67x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QSIQuantum-Si, Inc.81.73x -- $552K -$35.7M XTNTXtant Medical Holdings, Inc.0.67x 60.39x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 62.05% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 8.88% over the past day.
Sell
13
PSN alert for Dec 8
Parsons Corp. [PSN] is down 5.82% over the past day.
